Earle F. Burgess, MD
- Medical Oncology (Cancer)
Directions
Atrium Health Provider
Accepts New Patients
Treats Only AdultsAbout
Practicing Specialties
Clinical Interests
Languages
Credentials
Board Certifications
Education
Residencies
Fellowships
Locations
-
Atrium Health Levine Cancer Institute (GI & GU Cancer)Charlotte, NC 282041021 Morehead Medical DriveBuilding 1, Suite 5300
Accepted Insurance
Ratings and Reviews
Publications
Most Recent- Most Recent
- Alphabetical
- Oldest First
Enzalutamide and Docetaxel in Combination With Androgen Deprivation for Men With Metastatic Hormone-Sensitive Prostate Cancer: ENZADA, a Phase II Trial.
Burgess EF, Grigg CM, Boselli D, Symanowski JT, Golshayan A, Graham DL, Osei-Boateng K, Gavini N, Zhu J, Brown LC, Norek S, Begic XJ, Raghavan D
Thrombosis Rates and Genetic Thrombophilia Risk Among Patients With Advanced Germ Cell Tumors Treated With Chemotherapy.
Brown LC, Robinson M, McCormack M, Steuerwald N, Symanowski J, Sha W, Bose R, Neelands B, Akinyelu T, Livasy C, Li W, Haynes N, Hamilton A, Smith M, Clark PE, Patel J, Burgess EF
Molecular analysis of primary and metastatic sites in patients with renal cell carcinoma.
Gulati S, Barata PC, Elliott A, Bilen MA, Burgess EF, Choueiri TK, Darabi S, Dawson NA, Gartrell BA, Hammers HJ, Heath EI, Magee D, Rao A, Ryan CJ, Twardowski P, Wei S, Brugarolas J, Zhang T, Zibelman MR, Nabhan C, McKay RR
Renal cell carcinoma histologic subtypes exhibit distinct transcriptional profiles.
Barata P, Gulati S, Elliott A, Hammers HJ, Burgess E, Gartrell BA, Darabi S, Bilen MA, Basu A, Geynisman DM, Dawson NA, Zibelman MR, Zhang T, Wei S, Ryan CJ, Heath EI, Poorman KA, Nabhan C, McKay RR
Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial.
Siefker-Radtke AO, Matsubara N, Park SH, Huddart RA, Burgess EF, Özgüroğlu M, Valderrama BP, Laguerre B, Basso U, Triantos S, Akapame S, Kean Y, Deprince K, Mukhopadhyay S, Loriot Y, THOR cohort 2 investigators
Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma.
Loriot Y, Matsubara N, Park SH, Huddart RA, Burgess EF, Houede N, Banek S, Guadalupi V, Ku JH, Valderrama BP, Tran B, Triantos S, Kean Y, Akapame S, Deprince K, Mukhopadhyay S, Stone NL, Siefker-Radtke AO, THOR Cohort 1 Investigators
Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer.
O'Donnell PH, Milowsky MI, Petrylak DP, Hoimes CJ, Flaig TW, Mar N, Moon HH, Friedlander TW, McKay RR, Bilen MA, Srinivas S, Burgess EF, Ramamurthy C, George S, Geynisman DM, Bracarda S, Borchiellini D, Geoffrois L, Maroto Rey JP, Ferrario C, Carret AS, Yu Y, Guseva M, Homet Moreno B, Rosenberg JE
RNA-Based Homologous Recombination Deficiency Signature Detects Homologous Recombination Deficiency-RNA+ Patients With and Without Homologous Recombination Repair Gene Pathogenic Alterations in Men With Prostate Cancer.
Brown LC, Zhu J, Mauer E, Thiede SN, Macera L, Stein MM, Taxter T, Raghavan D, Burgess EF
COVID-19 vaccine uptake trends in SARS-CoV-2 previously infected cancer patients.
Shahid Z, Patrick AL, Wallander ML, Donahue EE, Trufan SJ, Tan AR, Hwang JJ, Burgess EF, Ragon B, Ghosh N, Grunwald MR, Voorhees PM, Copelan EA, Raghavan D
Low co-expression of PD-L1 and oncogenic receptor tyrosine kinases HER2 and cMET in urothelial carcinoma is associated with discordant expression between primary and metastatic sites.
Burgess EF, Livasy CA, Symanowski JT, Matulay JT, Grigg CM, Clark PE, Raghavan D
87 patient reviews
Most RecentI selected this practice because of excellent past experiences. The entire staff provide a service quality far better than other practices. Knowledgeable and caring to provide an excellent patient experience in this office visit.
I have seen Dr Burgess and his staff for the last few years. They are excellent and professional.
Dr.Burgess,Pam,and staff are like family to me. Professional and caring describe them.
He is the most wonderful Doctor I have ever had. He doesn't drag his feet when there is something that has to be done. He gets right on the problem. I am so lucky to have him as my doctor.
Thanks, keep up the good work ?
Dr. Burgess and Nurse Pam provide exceptional care. They have gone out of their way to accommodate my pill swallowing difficulties by finding alternative medications and coordinating with my insurance carrier and pharmacies. Best care imaginable.
Dr. Burgess is very matter of fact, which I prefer. I'm looking for honest, factual, moving forward information and approach and he offers that. Recommend him highly.
Over the past 7 years, I view my doctor and his staff as a trusted medical advisor.
Top of the line care!
Dr. Burgess and his team are outstanding!